JP Morgan highlights mixed sentiment for U.S. large-cap biopharma stocks as advancements in obesity drugs and key product launches shape 2025 outlook. Galapagos NV plans to split into two entities ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

**NM signifies a non meaningful value. A dash signifies the data is not available.

In a phase 2 trial, an antiretroviral combination developed by Gilead Sciences and MSD suppressed HIV with a single weekly oral dose, raising the hope of a new treatment option for patients.

Gilead has grown to become a leader in the fight against HIV and has announced efforts to improve access to a new, highly effective medicine. However, Ben Hargreaves finds that the company’s ...

After hours: 7:37:49 p.m. EST ...

After hours: January 23 at 6:55:18 PM EST ...

$ 92.21-0.86-0.92% ...

“People would say ‘Oh, here comes Mr. Frink,'” recalled one of his daughters, Justine Frink-Robinson ... mason and became a fixture of Mount Gilead Baptist Church. In 1969, he was ...